Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ChemAxon Resource Report Resource Website 1000+ mentions |
ChemAxon (RRID:SCR_004111) | ChemAxon | commercial organization | Commercial organization that provides cheminformatics software platforms, applications and services to optimize the value of chemistry information in life science and other R&D. This software enables structure visualization and management, property predictions and calculations, virtual synthesis, screening, clustering and drug design. | platform, cheminformatics, chemistry, toolkit | is related to: European Lead Factory | nlx_158589 | SCR_004111 | ChemAxon Kft., ChemAxon Kutat??-Fejleszt Kft. | 2026-08-01 12:02:30 | 1277 | ||||||||
|
European Lead Factory Resource Report Resource Website 1+ mentions |
European Lead Factory (RRID:SCR_003858) | ELF | nonprofit organization | Consortium that promotes the discovery of novel small molecule candidates suitable for subsequent optimization either to drug candidates or to high-quality pharmacological tools for the experimental validation of targets using open innovation and crowd sourcing. It is designed to provide best-in-class resources and funding-in-kind, to academics or small and medium enterprises (SMEs) who are working on promising biology targets or chemistry scaffolds. Screening of compounds to assess their activity is also funded and performed by the EU Lead Factory, with collaboration to help develop an Improved Hit List from the Qualified Hit List. They will provide collaborative screening of previously safeguarded, high quality corporate compounds. Around 300,000 compounds in the EFPIA Compound Collection, contributed by EFPIA members, will be screened against both commercially contributed biology targets and targets from public sources. The second phase of the consortium is to build a substantial new Public Compound Collection of around 200,000 compounds. Together, the EFPIA and Public compound collections will form a 500,000-strong Joint European Compound Collection. Target program owners and compound contributors will receive a Qualified Hit List (QHL) of up to 50 compounds complete with relevant information to help in the development of an Improved Hit List (IHL). Target program owners, will have exclusive access to threshold active compounds in their QHL. After the three-year exclusivity period, QHL/IHL information will be made public. Milestone payments are due if direct exploitation proceeds, not for research use. And owners and contributors will give EFPIA participants the right to submit a first bid (which they do not have to accept). | drug, crowd sourcing, drug candidate, pharmacological tool, target, oncology, drug discovery, drug development, lead structure, lead, compound, lead molecule, tool development, biomarker, small molecule, basic science, screening |
is listed by: Consortia-pedia is related to: Janssen Research and Development is related to: Merck is related to: BioAscent is related to: ChemAxon is related to: Edelris is related to: GABO:mi is related to: Lead Discovery Center is related to: Mercachem is related to: Pivot Park Screening Centre is related to: Sygnature Discovery is related to: Syncom is related to: Taros is related to: University of Dundee College of Life Sciences; Scotland; United Kingdom is related to: Leiden University; Leiden; Netherlands is related to: Max Planck Institute of Molecular Physiology; Dortmund; Germany is related to: Radboud University; Nijmegen; The Netherlands is related to: University of Groningen; Groningen; Netherlands is related to: Technical University of Denmark; Lyngby; Denmark is related to: TI Pharma is related to: University of Duisburg-Essen; North Rhine-Westphalia; Germany is related to: University of Leeds; West Yorkshire; United Kingdom is related to: University of Nottingham; Nottingham; United Kingdom is related to: VU University; Amsterdam; Netherlands has parent organization: TI Pharma has parent organization: Taros |
Innovative Medicines Initiative 115489; EFPIA |
nlx_158182, grid.498269.8 | https://ror.org/02gxafv90 | SCR_003858 | EU Lead Factory | 2026-08-01 12:02:21 | 6 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web. We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.
